Chang Xiubao, Hou Yuexian
Department of Biochemistry & Molecular Biology, College of Medicine, Mayo Clinic in ArizonaScottsdale, AZ, USA.
Int J Biochem Mol Biol. 2018 Feb 8;9(1):1-10. eCollection 2018.
Genome editing is a powerful tool to modify a specific gene and to correct a disease-causing mutation. Recently developed new techniques, such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALEN) and clustered regularly interspaced short palindromic repeats/Cas9 (CRISPR/Cas9), significantly facilitate the progression in this field. However, mutations associated with the double strand DNA breaks (DSBs) introduced by these systems hampered their direct usage in clinic. In order to prevent the mutations caused by DSBs, we have designed a novel mean to induce homology-directed recombination (HDR) without DSBs, i.e., the fusion protein of RecA with cell-penetrating peptide (CPP). The involvement of RecA in these fusion proteins will play important roles in formation of the nucleoprotein filament with single strand DNA (ssDNA) and promoting HDR ; whereas the involvement of CPP in these fusion proteins will mainly play a role in facilitating cellular intake/uptake of the nucleoprotein filaments. Our results indicated that certain amount of the fusion proteins expressed in bacteria is in soluble fraction, whereas majority of the fusion proteins expressed in baby hamster kidney (BHK) cells is in soluble fraction. Interestingly, expression of these fusion proteins in bacteria completely blocked cell growth, whereas expression of them in BHK cells significantly inhibited cell growth, implying that these fusion proteins may bind to ssDNA regions, such as ssDNA regions in DNA replication forks, and inhibit cell growth. These results suggest that we have functional RecA.CPP fusion proteins ready to test our novel idea of inducing HDR without DSB.
基因组编辑是一种用于修饰特定基因和纠正致病突变的强大工具。最近开发的新技术,如锌指核酸酶(ZFNs)、转录激活样效应因子核酸酶(TALEN)和成簇规律间隔短回文重复序列/Cas9(CRISPR/Cas9),显著推动了该领域的进展。然而,这些系统引入的与双链DNA断裂(DSB)相关的突变阻碍了它们在临床上的直接应用。为了防止由DSB引起的突变,我们设计了一种新方法来诱导无DSB的同源定向重组(HDR),即RecA与细胞穿透肽(CPP)的融合蛋白。RecA参与这些融合蛋白将在与单链DNA(ssDNA)形成核蛋白丝以及促进HDR中发挥重要作用;而CPP参与这些融合蛋白将主要在促进细胞摄取/吸收核蛋白丝方面发挥作用。我们的结果表明,在细菌中表达的一定量的融合蛋白存在于可溶部分,而在幼仓鼠肾(BHK)细胞中表达的大多数融合蛋白也存在于可溶部分。有趣的是,这些融合蛋白在细菌中的表达完全阻断了细胞生长,而它们在BHK细胞中的表达则显著抑制了细胞生长,这意味着这些融合蛋白可能与ssDNA区域结合,如DNA复制叉中的ssDNA区域,并抑制细胞生长。这些结果表明,我们已经有了功能性的RecA.CPP融合蛋白,可以用来测试我们诱导无DSB的HDR的新想法。